Sandoz will supply antibiotic to developing countries as part of the United Nations' Every Newborn Action Plan.
Sandoz has made a long-term commitment to supply a key antibiotic formulation as part of the United Nations' new Every Newborn Action Plan, which aims to eliminate preventable deaths of newborn and stillborn babies. The commitment involves providing long-term global supplies of amoxicillin 250 mg dispersible tablets to developing countries via the UN Commission for Lifesaving Commodities.
More than five million children under five are estimated to die worldwide every year, mainly in Africa and Asia, and nearly a quarter of those deaths are due to pneumonia alone, making it the single largest killer in that age range, a press release reported. In 2011, the World Health Organization updated its recommendations for home treatment of pneumonia, establishing dispersible amoxicillin as the newly recommended first-line treatment for pneumonia in children under five.
"Sandoz is proud to be jointly leading the response to the growing global need for this new formulation of a critical anti-infective", said Nick Haggar, head of Western Europe, Middle East, and Africa for Sandoz. "We are committed to working in partnership with all concerned to help prevent the needless deaths of hundreds of thousands of children every year. In our first year of supply, we hope to reach at least 500,000 children worldwide."
Sources: Sandoz
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.